Related references
Note: Only part of the references are listed.British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
Rebecca C. Fitzgerald et al.
GUT (2014)
Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus
Florine Kastelein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Bile Exposure Inhibits Expression of Squamous Differentiation Genes in Human Esophageal Epithelial Cells
Marie Reveiller et al.
ANNALS OF SURGERY (2012)
Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux
Ayman O. Nasr et al.
SURGERY (2012)
Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia
K. R. McQuaid et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Effect of Proton-Pump Inhibitor Therapy on Serum Chromogranin A Level
Istvan Pregun et al.
DIGESTION (2011)
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Stuart J. Spechler et al.
GASTROENTEROLOGY (2011)
Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study
Shivaram Bhat et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Incidence of Adenocarcinoma among Patients with Barrett's Esophagus
Frederik Hvid-Jensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus
Anne L. Krarup et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Dyspeptic Symptoms and Endoscopic Findings in the Community: The Loiano-Monghidoro Study
Rocco Maurizio Zagari et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Elevated Serum Gastrin Is Associated With a History of Advanced Neoplasia in Barrett's Esophagus
Judy S. Wang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
What Is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Systematic Review and Meta-analysis
Alexander C. Ford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
Marjolein Sikkema et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo
Jolanta A. Obszynska et al.
GUT (2010)
Correlation between serum gastrin and cellular proliferation in Barrett’s esophagus
Daniel A. Green et al.
Therapeutic Advances in Gastroenterology (2010)
Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank
Erichsen
Clinical Epidemiology (2010)
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
Brian J. Reid et al.
NATURE REVIEWS CANCER (2010)
Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Prevalence of Complicated Gastroesophageal Reflux Disease and Barrett's Esophagus Among Racial Groups in a Multi-Center Consortium
Amy Wang et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation
Ian L. P. Beales et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
Medical Treatment of Barrett's Esophagus: Can It Prevent Cancer?
Richard E. Sampliner
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Glycine-extended gastrin stimulates proliferation via JAK2-and Akt-dependent NF-κB activation in Barrett's oesophageal adenocarcinoma cells
Olorunseun O. Ogunwobi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus
L. C. Hillman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Using prescription claims data for drugs available over-the-counter (OTC)
Marianne Ulcickas Yood et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Proton pump inhibitor use and risk of colorectal cancer: A population-based, case-control study
Douglas J. Robertson et al.
GASTROENTEROLOGY (2007)
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK
L. A. Garcia Rodriguez et al.
GUT (2006)
Gastro-oesophageal reflux disease
Paul Moayyedi et al.
LANCET (2006)
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence
BT Cooper et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Prevalence of Barrett's esophagus in the general population:: An endoscopic study
J Ronkainen et al.
GASTROENTEROLOGY (2005)
Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus
HB El-Serag et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage - A population-based case-control study
SP Johnsen et al.
STROKE (2003)
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus
RF Souza et al.
GASTROENTEROLOGY (2002)
Barrett's oesophagus, dysplasia and pharmacologic acid suppression
RC Fitzgerald et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
